Keyphrases
QT Prolongation
96%
T Cells
74%
Clinical Outcomes
68%
Tertiary Care Hospital
66%
Hospitalized Patients
64%
Pyroglutamic Acid
64%
Voriconazole
64%
Systemic Sclerosis
64%
Pyroglutamic Acidosis
64%
Anion Gap Metabolic Acidosis
64%
Hypomagnesemia
58%
Retrospective Cohort Study
54%
Clinical Decision Support Systems
48%
Alert Fatigue
48%
Israel
48%
Clinically Significant
45%
Prescribers
42%
Electronic Prescription
42%
Zoledronate
41%
Health Maintenance Organizations
40%
Internal Medicine Wards
40%
Prescription Errors
40%
Risk Factors
39%
First Year
38%
Warfarin
37%
Isopentenyl Pyrophosphate
36%
Pharmacokinetics
36%
Serum Magnesium
35%
Multivariate Analysis
34%
Oncology Patients
32%
Incidental
32%
Morbid Obesity
32%
Papaverine
32%
Fibroblast Apoptosis
32%
Within-individual Variability
32%
Dose Prediction
32%
Antifibrotic
32%
Warfarin Dose
32%
Thiopurines
32%
VKORC1
32%
Dose Requirement
32%
Atrial Fibrillation
32%
Clinical Characteristics
32%
Proton Pump Inhibitors
32%
Heart Transplant
32%
Pregnancy Outcome
32%
Clinical Risk
32%
Direct Oral Anticoagulants
32%
Drug Alerts
32%
Alert Override
32%
Medicine and Dentistry
Prospective Study
64%
Clinical Decision Support System
64%
Tertiary Care
64%
Voriconazole
64%
Electronic Prescribing
53%
Internal Medicine
48%
Health Care Cost
42%
Zoledronic Acid
41%
T Cell
40%
Hypomagnesemia
32%
Anion Gap
32%
Isopentenyl Diphosphate
32%
Proton-Pump Inhibitor
32%
Retrospective Study
32%
Pediatrics
32%
QT Prolongation
32%
Acidosis
32%
Bisphosphonate
32%
Drug Prescription
32%
Illicit Drug
32%
Systemic Scleroderma
32%
Metabolic Acidosis
32%
Drug Therapy
32%
Papaverine
32%
Drug Interaction
26%
Multivariate Analysis
24%
QTc Interval
20%
Electronic Patient Record
20%
Lavage
16%
Contrast Medium
16%
Infusion
16%
Serositis
16%
Clinical Feature
16%
Cancer
16%
Combination Therapy
16%
Surgery
16%
Urinary System
16%
Watchful Waiting
16%
Magnesium
16%
Hospital Management
16%
Drug Intoxication
16%
Abdominal X-Ray
16%
Bowel Obstruction
16%
Medical Imaging
16%
Cannabinoid
16%
Decision Making
16%
Cesarean Section
16%
First Trimester Pregnancy
16%
Congenital Malformation
16%
Premature Labor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Prospective Study
96%
Pyroglutamic Acid
64%
Voriconazole
64%
Warfarin
64%
Electronic Prescribing
64%
Metabolic Acidosis
64%
Pharmacokinetics
36%
Infection
34%
QT Prolongation
32%
Mercaptopurine
32%
Isopentenyl Diphosphate
32%
Upper Gastrointestinal Bleeding
32%
Acute Disease
32%
Drug-Drug Interaction
32%
Tacrolimus
32%
Direct Oral Anticoagulant
32%
Potassium Chloride
32%
Cholinergic Receptor Blocking Agent
32%
Prospective Cohort Study
32%
Trough Level
32%
Papaverine
32%
Imatinib
32%
Pharmacogenetics
32%
Systemic Sclerosis
32%
Retrospective Study
32%
Creatinine
17%
Congenital Malformation
16%
Premature Labor
16%
Bleeding
16%
Low Birth Weight
16%
Elimination
14%
Cytokine
12%
Toxic Shock Syndrome Toxin 1
12%
Isotopes of Potassium
12%
Thromboembolism
12%
Disease
11%
Triacylglycerol
10%
Small for Date Infant
10%
Perinatal Death
10%
Procollagen
9%
Zoledronic Acid
9%
Septic Shock
9%
Tioguanine
8%
Electrolyte Disturbance
8%
Rivaroxaban
8%
Hospital Mortality
6%
Cardiovascular Disease
6%
Interferon
6%
Tumor Necrosis
6%
